1. Older people have substantial interindividual variability in health, disability, age-related changes, polymorbidity, and associated polypharmacy, making generalization of prescribing recommendations difficult. 2. Medication use in older adults is often inappropriate and erroneous, partly because of the complexities of prescribing and partly because of many patient, provider, and health system factors that substantially influence the therapeutic value of medications in aged people. 3. A high prevalence of medication errors in older adults results on the one hand from accumulation of factors that contribute to medication errors in all age groups, such as polypharmacy, polymorbidity, enrollment in several disease-management programmes, and fragmentation of care. On the other hand, specific geriatric aspects play a role in these medication errors; these include age-related pharmacological changes, lack of specific evidence on the efficacy and safety of medications, underuse of comprehensive geriatric assessment, less availability of drug formulations offering geriatric doses, and inadequate harmonization of geriatric recommendations across Europe. 4. The dearth of geriatric clinical pharmacology and clinical pharmacy services compounds the difficulties. 5. There are gaps in research and clinical practice that lead to frequent medication errors in older adults, which must be solved by future studies and by regulatory measures in order to support errorless and appropriate use medications in these people.

Department of Geriatrics and Gerontology 1 Faculty of Medicine Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

Population and Development: Programme of Action Report of the International Conference on Population and Development. New York: United Nations Publications; 1999. Cairo 5–13 September 1994. ST/ESA/SER.A/149. Sales No. E.95.XIII.7.

Maxwell SR, Webb DJ. Clinical pharmacology – too young to die? Lancet. 2006;367:799–800. PubMed

Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M, Onder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R, AdHOC Project Research Group Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348–58. PubMed

Johnssons JA, Bootman JL. Drug-related morbidity and mortality. Arch Intern Med. 1995;155:1949–56. PubMed

Burton MM, Hope C, Murray MD, Hui S, Overhage JM. The cost of adverse drug events in ambulatory care. AMIA Annu Symp Proc. 2007;11:90–3. PubMed

Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49:200–9. PubMed

Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck J. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825–32. PubMed

Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med. 1997;157:1531–6. PubMed

Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–24. PubMed

McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156:385–91. PubMed PMC

Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63:725–31. PubMed

De Smet PA, Denneboom W, Kramers C, Grol R. A composite screening tool for medication reviews of outpatients: general issues with specific examples. Drugs Aging. 2007;24:733–60. PubMed

Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84. PubMed

Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008;37:673–9. PubMed

Shelton PS, Fritsch MA, Scott MA. Assessing medication appropriateness in the elderly: a review of available measures. Drugs Aging. 2000;16:437–50. PubMed

Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312:71–2. PubMed PMC

Godlovitch G. Age discrimination in trials and treatment: old dogs and new tricks. Monash Bioeth Rev. 2003;22:66–77. PubMed

Beswick A, Burke M, Shlomo YB, Dieppe P. PREDICT. Increasing the participation of elderly in clinical trials. Work package 1. Literature review. Medical Research Council (MERCS), Nov 2008: 143.

MERCS. Sinclair-Cohen J. There need to be more elderly people in clinical trials, says European consortium PREDICT. Press release 20 Jan 2009. Available at: http://cordis.europa.eu/wire/index.cfm?fuseaction=article.Detail&rcn=18648 (last accessed 7 February 2009.

Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, Kösters JP, Vernby A. Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev. 1): CD007017. PubMed

Bernabei R, Landi F, Onder G, Liperoti R, Gambassi G. Second and third generation assessment instruments: the birth of standardization in geriatric care. J Gerontol A Biol Sci Med Sci. 2008;63:308–13. PubMed

Morris JN, Fries BE, Steel K, Ikegami N, Bernabei R, Carpenter GI, Gilgen R, Hirdes JP, Topinková E. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc. 1997;45:1017–24. PubMed

Fries BE, Morris JN, Bernabei R, Finne-Soveri H, Hirdes J, interRAI Consortium Rethinking the resident assessment protocols. J Am Geriatr Soc. 2007;55:1139–40. PubMed

Hirdes JP, Ljunggren G, Morris JN, Frijters DH, Finne Soveri H, Gray L, Björkgren M, Gilgen R. Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system. BMC Health Serv Res. 2008;8:277. PubMed PMC

Landi F, Tua E, Onder G, Carrara B, Sgadari A, Rinaldi C, Gambassi G, Lattanzio F, Bernabei R, SILVERNET-HC Study Group of Bergamo Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care. 2000;38:1184–90. PubMed

Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies)

Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients